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Abstract
Nontypable Haemophilus influenzae (NTHi) has emerged as an important opportunistic pathogen causing infection in adults
suffering obstructive lung diseases. Existing evidence associates chronic infection by NTHi to the progression of the chronic
respiratory disease, but specific features of NTHi associated with persistence have not been comprehensively addressed. To
provide clues about adaptive strategies adopted by NTHi during persistent infection, we compared sequential persistent
isolates with newly acquired isolates in sputa from six patients with chronic obstructive lung disease. Pulse field gel
electrophoresis (PFGE) identified three patients with consecutive persistent strains and three with new strains. Phenotypic
characterisation included infection of respiratory epithelial cells, bacterial self-aggregation, biofilm formation and resistance
to antimicrobial peptides (AMP). Persistent isolates differed from new strains in showing low epithelial adhesion and
inability to form biofilms when grown under continuous-flow culture conditions in microfermenters. Self-aggregation
clustered the strains by patient, not by persistence. Increasing resistance to AMPs was observed for each series of persistent
isolates; this was not associated with lipooligosaccharide decoration with phosphorylcholine or with lipid A acylation.
Variation was further analyzed for the series of three persistent isolates recovered from patient 1. These isolates displayed
comparable growth rate, natural transformation frequency and murine pulmonary infection. Genome sequencing of these
three isolates revealed sequential acquisition of single-nucleotide variants in the AMP permease sapC, the heme acquisition
systems hgpB, hgpC, hup and hxuC, the 3-deoxy-D-manno-octulosonic acid kinase kdkA, the long-chain fatty acid transporter
ompP1, and the phosphoribosylamine glycine ligase purD. Collectively, we frame a range of pathogenic traits and a
repertoire of genetic variants in the context of persistent infection by NTHi.
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Introduction
Chronic respiratory diseases including chronic obstructive
pulmonary disease (COPD), bronchiectasis or cystic fibrosis (CF)
often progress with lower airways colonization by pathogenic
microorganisms and, in many cases, chronic infections are
established. Chronic infection sets up a condition where microbial
antigens induce a host inflammatory response and disrupt the
innate lung defense. These aspects are thought to play a key role in
the irreversible airway damage from which some patients
ultimately die [1–4].
Haemophilus influenzae is a human-restricted respiratory pathogen
that can either be capsulated (typable) or unencapsulated
(nontypable). Encapsulated strains generally cause systemic
infections, e.g., bacteremia and meningitis, whereas nontypable
H. influenzae (NTHi) strains often cause non-invasive mucosal
infections, e.g., otitis media, sinusitis, and conjunctivitis. Impor-
tantly, NTHi is encountered in a significant proportion in the
lower airways of chronic patients suffering COPD, bronchiectasis
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or CF [5]. Studies addressing the hallmarks of H. influenzae
infection in adult patients with obstructive lung diseases have been
focused on COPD, where infection by NTHi is regarded as a
marker of severe obstructive airflow and progression of the disease,
and has been associated with decline in lung function and
mortality [2]. Screening of COPD patients for H. influenzae during
both scheduled and exacerbative assessments revealed persistent
colonization with identical NTHi strains [6]. Genetic features
associated with persistent NTHi strains are: (i) changes in the
sequence of the outer membrane protein encoding ompP2 gene
over time [7,8]; (ii) phase variation in the hmw1A and hmw2A genes,
leading into a decreased expression of HMW1A and HMW2A
adhesins over time [9]; (iii) adaptation in COPD of a clonally
related group of NTHi strains with two IgA1 protease genes (iga
and igaB) [10]. Conversely, acquisition of a new NTHi strain has
been shown to be an important cause of lower respiratory tract
infection associated with the occurrence of COPD exacerbations
[11]. Newly acquired strains, isolated for the first time at
exacerbation symptom onset, seem to mediate more neutrophil
recruitment, adhere to epithelial cells in higher numbers, and
induce more interleukin-8 (IL-8) release after interaction with
airway epithelial cells than colonizers, isolated when the patient
had no clinical signs of exacerbation [12]. Evidence also indicates
that adults with COPD make new antibodies to strain-specific,
surface-exposed epitopes on H. influenzae after exacerbations, and
that the strain specificity of the immune response may favor
further exacerbation by new strains [13]. Also, new strain
exacerbations are associated with significantly greater increases
from baseline in sputum TNF-a, neutrophil elastase and serum C-
reactive protein than preexisting strain exacerbations [14].
Altogether, existing evidence suggests that persistent NTHi
isolates may display differential features. In this study, we question
whether series of persistent NTHi isolates with identical PFGE
profile, recovered from consecutive acute exacerbations from three
adults with a chronic lung disease, patients 1, 2 and 3, present
distinctive genotypic or phenotypic features that could relate to
persistence. These three retrospective series of NTHi isolates were
tested in terms of cultured human respiratory epithelial infection,
self-aggregation, biofilm formation and resistance to antimicrobial
peptides (AMPs). Results were compared with those obtained on a
panel of newly acquired isolates causing acute exacerbations.
Comparison was made between isolates overall, between persistent
and newly acquired strains, and between sequential clonal isolates
within a patient. We further characterized the series of three
isolates recovered from patient 1 in terms of growth rate, natural
transformation frequency and mouse pulmonary infection. Finally,
we genome sequenced this series of three clonal isolates collected
from patient 1, which revealed a range of nonsynonymous single-
nucleotide variants (SNVs) potentially linked to the observed
phenotypes. Overall, we present a number of phenotypic and
genomic traits that could be relevant for NTHi persistent infection.
Methods
Ethics Statement
This work was approved by the ‘Comite´ Etic d’Investigacio´
Clı´nica, Hospital Universitari Bellvitge (HUB, Spain). A written or
oral informed consent was considered not necessary because the
source of bacterial isolates was anonymous and the study was
retrospective. The institutional review board waived the need for
written informed consent.
Bacterial Isolates
From January 1997 to January 2003, a collection of NTHi
isolates obtained from sputum samples from adult respiratory
patients seen at the HUB was cryopreserved at 280uC. Sputa
were collected during acute exacerbation, defined as any sustained
increase in respiratory symptomatology compared with the
baseline situation and requiring an increase in regular medication
and hospital treatment. NTHi isolates were identified by
conventional methodology and by mass spectrometry using a
MALDI-Biotyper version 3.0 (Bruker), following the manufactur-
er’s recommendations. Serotyping was achieved with the latex
agglutination Phadebact Haemophilus Test (Bactus AB). For this
study, a retrospective review of computerized microbiological and
medical charts was performed in patients seen at HUB during this
period suffering a chronic lung disease, and with two or more
cryopreserved NTHi isolates. Only NTHi isolates from good
quality sputum samples (,10 squamous cells and .25 leukocytes
per low-power field) and with a predominance of Gram negative
cocobacillary forms were considered [15]. We selected 18 NTHi
isolates from 6 patients with chronic lung disease and with 2 or
more episodes of acute exacerbations due to NTHi (Table 1).
Pulse Field Gel Electrophoresis (PFGE) and Molecular
Typing
Strain relatedness was determined by PFGE. PFGE typing was
performed on bacterial suspensions of H. influenzae grown on
chocolate agar plates, as previously described [16,17], with some
modifications [18]. Briefly, bacterial suspensions were prepared in
PIV (10 mM Tris-HCl [pH 8], 1 M NaCl) and adjusted to the
same final concentration. The bacterial suspension was mixed with
an equal volume of melted 1.5% low-melting point agarose (Life
Technologies), to prepare DNA-agarose plugs with a volume of
20 ml each. These were incubated for 5 h at 37uC in 1 ml of ST
buffer (6 mM Tris-HCl [pH 8]; 1 M NaCl; 0.1 M EDTA [pH 8])
containing 0.5% Brij-58, 100 mg/mL lysozyme and 50 mg/ml
RNAse. The agarose plugs were transferred into ES buffer (1 M
EDTA, 1% sarcosyl) with 1 mg/mL proteinase K (Sigma) and
incubated for 16 h at 50uC. The plugs were rinsed three times at
room temperature with TE buffer (10 mM Tris-HCl [pH 8];
1 mM EDTA [pH 8]). The DNA-embedded plugs were digested
with 5 U of SmaI (New England BioLabs) for 18 h at 25uC. DNA
fragments were then separated in a 1% agarose gel (Megabase,
BioRad) with 0.5% TBE buffer (45 mM Tris-base, 45 mM boric
acid, 1.0 mM EDTA pH 8.0) in a contour-clamped homogenous
electric field system (CHEF DR III; BioRad). Gels were run for
19 h at 14uC, using a constant voltage of 6 V/cm with an angle of
120u and an increasing pulse time from 1 s to 30 s. A
bacteriophage l low-range PFG marker (New England BioLabs)
was used as a size standard. PFGE band patterns were analysed
using the Fingerprinting II Software 3.0 (BioRad). Each cluster
received a PFGE profile, named with a capital letter (Table 1).
Persistent isolates were defined as those recovered in consecutive
episodes from the same patient showing an identical PFGE
pattern. A new acquired isolate was considered when its PFGE
pattern was different to that of the strain isolated in the previous
episode suffered by the same patient [19].
When required, chromosomal DNA was isolated. The lgtF,
lic2A, lic3A, lic3B and ompP5 genes were PCR-amplified using
primers previously described [17]. For lpsA, primers lpsa-F1 (59-
TACTTAGCTCGCATTCTCAGGGCAGGGTGA) and lpsa-
R1 (59-AACACTCAAATGCTCATCAGAACAGGCTGA) were
used. For lic1A, primers lic1A-F1 (59-TCCACTATTAGGC-
GAAACCTTAGCTTC) and lic1A-R1 (59-TAAATAACGAGT-
CAGTTTTACGCCACTT) were used. For hmw1A, primers
NTHi Chronic Infection of Patients with Obstructive Lung Diseases
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hmw1A-7D (59-CACTCGCTAGTGGTTGTTAATGATGAA)
and hmw1A-rec-R1 (59-GATTCGCAGAGATAGATT-
GACCTTTTG) were used. For sapC, primers sapC-F1 (59-
ATGCAAAATAAAGAACCTGATGAA), sapC-F2 (59-
GTTTATGGAATGCAATGTTTGCTA), sapC-R1 (59-
CTATTCTTGATGTTGATTGATGGC) and sapC-R2 (59-
ATACCTTTCAGTAGTCCTGCAATA) were used. For kdkA,
primers kdkA-F1 (59-ATGCACCAATTCCAACAAGATAAC)
and kdkA-R1 (59-TTATTGATGATAAGCTGACGTTAA) were
used. For lic1A, ompP5, sapC and kdkA, PCR products were Sanger
sequenced.
Colony Immunoblot
PCho level was assessed as described previously, using mouse
anti-PCho TEPC-15 antibody (Sigma) [20].
Antimicrobial Susceptibility Testing
Antimicrobial susceptibility was determined by microdilution
according to the criteria of the Clinical Laboratory Standards
Institute (CLSI) [21,22]. Ampicillin, amoxicillin-/clavulanic acid,
cefuroxime, cefotaxime, ceftriaxone, imipenem, meropenem,
tetracycline, chloramphenicol, trimethoprim/sulfamethoxazole,
azithromycin, ciprofloxacin, levofloxacin and rifampin were
tested. b-lactamase production was screened using the chromo-
genic cephalosporin method (nitrocefin disks, BD).
Growth analysis
Growth was measured by using a BioScreen C instrument
(BioScreen Instruments Pvt. Ltd.). Nine to twelve colonies of each
strain were dispersed into 2 ml of sBHI medium, and 200 ml was
added to wells of a BioScreen 100-well plate. Wells along the edges
of each plate contained sBHI medium alone, as these wells were
previously found to have anomalously slow growth, likely due to a
lower temperature at the edges. Plates were incubated in the
BioScreen plate at 37uC with agitation, and the OD600 was
measured every 10 min for 24 h. The growth curve of each well
was baseline corrected to its minimum value (these values were
always within the range of values of control wells), and the average
OD600 of the replicates at each time point was calculated.
Transformation assays
H. influenzae cells were made competent by the transfer of sBHI
medium-grown cells into MIV medium at an OD600 of 0.3 and
incubation for 100 min at 37uC, as described previously [23].
These cells were incubated with 1 mg of MAP7 chromosomal
DNA [23] per 1 ml of culture for 15 min at 37uC. Cells were then
diluted and plated onto sBHI agar with and without novobiocin or
nalidixic acid. Transformation frequencies were calculated as the
number of novobiocin-resistant (Novr), nalidixic acid-resistant
(NalR) transformants per cell.
Antimicrobial Peptide Susceptibility Assay
Antimicrobial peptide susceptibility was assessed as described
previously [24], adapted for H. influenzae. Bacteria grown on 10 ml
sBHI were harvested (35006r.p.m, 20 min, 20uC) in exponential
growth (OD650 = 0.3). Bacteria were washed once with PBS and a
suspension containing 105 c.f.u./ml was prepared in 10 mM PBS
(pH 6.5), 1% tryptone soy broth (Oxoid) and 100 mM NaCl.
Aliquots (5 ml) of this suspension were mixed in 1.5 ml micro-
centrifuge tubes with various concentrations of polymyxin B (PxB)
(prepared in 10 mM PBS (pH 6.5), 1% TSB and 100 mM NaCl).
In all cases, the final volume was 30 ml. After 30 or 60 min of
incubation at 37uC, the content of the tubes was plated on
sBHI-agar. Alternatively, 5 ml of the bacterial suspensions were
mixed with 25 ml of various concentrations of human b-defensin 1
(prepared in 10 mM PBS (pH 6.5), 1% TSB and 100 mM NaCl),
incubated 1 h at 37uC, and plated on sBHI-agar. Colony counts
were determined. Results are expressed as percentage of the
colony count of bacteria not exposed to the antibacterial agent.
Experiments were performed with duplicate samples on at least
three independent occasions (n$6). Mean6SD were calculated,
and statistical comparison of means was performed using the two-
tail t test (Prisma4 for PC). A p,0.05 value was considered
statistically significant.
Lipid A Purification and Analysis
Lipid A was extracted using an ammonium hydroxide/
isobutyric acid method and subjected to negative-ion matrix-
assisted laser desorption ionization time-of-flight (MALDI-TOF)
mass spectrometry analysis [25]. NTHi isolates were grown on
chocolate-agar plates; when required, strains were grown on sBHI-
agar plates in the presence of a sub-lethal concentration of PxB
(0.5 USP units/ml). Freshly grown bacteria were scraped from the
plates, resuspended in 400 ml of isobutyric acid–1 M ammonium
hydroxide (5:3 [vol/vol]) and incubated in a screw-cap test tube at
100uC for 2 h, with occasional vortexing. Samples were cooled in
ice water and centrifuged (2,0006g for 15 min). The supernatant
was transferred to a new tube, diluted with an equal volume of
water, and lyophilized. The sample was then washed twice with
400 ml of methanol and centrifuged (2,0006g for 15 min). The
insoluble lipid A was solubilized in 100 to 200 ml of chloroform-
methanol-water (3:1.5:0.25 [vol/vol/vol]). Analyses were per-
formed on a Bruker Autoflex II MALDI-TOF mass spectrometer
(Bruker Daltonics, Inc.) in negative reflective mode with delayed
extraction. The ion-accelerating voltage was set at 20 kV. To
analyze the samples, 1 to 3 ml of lipid A suspension (1 mg/ml)
were desalted with a few grains of ion-exchange resin (Dowex
50W-X8; H) in a 1.5 ml microcentrifuge tube. A 1 ml aliquot of
the suspension (50 to 100 ml) was deposited on the target and
covered with the same amount of dihydroxybenzoic acid matrix
(Sigma) dissolved in 0.1 M citric acid. Different ratios between the
samples and dihydroxybenzoic acid were used when necessary.
Alternatively, lipid A was mixed with 5-chloro-2-mercapto-
benzothiazole (Sigma) at 20 mg/ml in chloroform-methanol (1:1
[vol/vol]) at a ratio of 1:5. Each spectrum was an average of 300
shots. A peptide calibration standard (Bruker Daltonics) was used
to calibrate the MALDI-TOF. Further calibration for lipid A
analysis was performed externally using lipid A extracted from E.
coli strain MG1655. Interpretation of the negative-ion spectra is
based on earlier studies showing that ions with masses higher than
1,000 gave signals proportional to the corresponding lipid A
species present in the preparation [26–29].
Bacterial Aggregation Assay
Three or four colonies of NTHi or E. coli grown on chocolate-
agar or LB-agar plates, respectively, were inoculated into 20 ml
sBHI (NTHi) or LB (E. coli) media, grown overnight, diluted in the
same medium to OD600 nm = 1, and left standing at room
temperature for 7 h (starting volume ,20 ml). The viability of
each culture was tested by serial dilution and plating on sBHI-agar
or LB-agar at the beginning of each experiment (t = 0). OD600 nm
readings were performed at regular time intervals on 500 ml
aliquots collected from the top of each bacterial suspension. At
least four independent experiments (n$4) were performed for each
strain. Mean6SD were calculated, and statistical comparison of
means was performed using the one-way ANOVA followed by the
Fisher’s Protected Least Significant Differences (PLSD) tests
NTHi Chronic Infection of Patients with Obstructive Lung Diseases
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(StatViewGraphics 5.0 for Windows (SAS Institute Inc). A p,
0.05 value was considered statistically significant.
Biofilm Formation
Biofilm formation under flow conditions was assessed using
60 ml microfermenters (Pasteur Institute, Laboratory of Fermen-
tation) with a continuous flow of medium (40 ml/h) and constant
aeration with sterile compressed air (0.3 bar). Submerged Pyrex
glass slides served as the growth substratum. Three or four colonies
of each strain grown on chocolate-agar plates were inoculated in
20 ml sBHI medium and incubated under shaking up to
OD600 nm = 1. ,108 bacteria from this culture were used to
inoculate the microfermenter, which was run at 37uC for 16 h.
The viability of each inoculated bacterial aliquot was tested by
serial dilution and plating on sBHI-agar. To quantify the biofilm
formed, bacteria adhered to the Pyrex slides were resuspended in
10 ml PBS. The OD600 nm of the suspensions was determined.
Experiments were performed on at least three independent
occasions (n$3). Mean6SD were calculated, and statistical
comparison of means was performed using the two-tail t test
(Prisma4 for PC). A p,0.05 value was considered statistically
significant.
Cell Culture and Bacterial Infection
A549 human immortalised type II pneumocytes, ATCC CCL-
185, were maintained as previously described [30]. Cells were
seeded to 66104 cells/well in 24-well tissue culture plates for 32 h
and serum-starved for 16 h before infection by replacement of
medium lacking FBS. A confluence of 90% was reached at the
time of infection. When necessary, cells were seeded for a longer
period of time to reach an over-confluent monolayer (approxi-
mately 86105–16106 cells/well). Stationary phase grown NTHi
were recovered with 1 ml PBS from a chocolate-agar plate and
adjusted to OD600 = 1 (10
9 c.f.u./ml). Cells were infected in 1 ml
EBSS (Earle’s Balance Salt Solution) with the freshly obtained
bacterial suspension, at approximately MOI 100:1, for 30 min,
washed five times with PBS, and lysed with 300 ml of PBS-Saponin
0.025% for 10 min at room temperature. Serial dilutions were
plated on sBHI-agar and adhesion scored as c.f.u./well. Exper-
iments were performed in triplicate on at least three independent
occasions (n$9). Mean6SD were calculated, and statistical
comparison of means was performed using the two-tail t test
(Prisma4 for PC). A p,0.05 value was considered statistically
significant.
Secretion of IL-8
A549 cells were maintained and infected for 2 h, as described
above. Cells were washed 3 times with PBS, and incubated with
fresh medium containing gentamicin (100 mg/ml) for 6 or 20 h.
Supernatants were removed from the wells, cell debris was
removed by centrifugation, and samples were frozen at 280uC.
IL-8 levels in the supernatants were measured using an ELISA kit
(Innova). Infection experiments were carried out in duplicate and
on at least two independent occasions (n$4). Mean6SD were
calculated, and statistical comparison of means was performed
using the two-tail t test (Prisma4 for PC). A p,0.05 value was
considered statistically significant.
Mouse Assays
A mouse model of NTHi pulmonary infection was used, as
described previously [31]. CD1 female mice (4 to 5 weeks old)
were purchased from Charles River Laboratories (France) and
housed under pathogen-free conditions at the Institute of
Agrobiotechnology of the Universidad Pu´blica de Navarra
(UPNA) facilities (registration number ES/31-2016-000002-CR-
SU-US). Animal handling and procedures were in accordance
with the current European (Directive 86/609/EEC) and National
(Real Decreto 53/2013) legislations, following the FELASA and
ARRIVE guidelines, and with the approval of the UPNA Animal
Experimentation Committee (Comite´ de E´tica, Experimentacio´n
Animal y Bioseguridad-CEEAB, http://www.unavarra.es/invest/
comiteEtica.htm) and the local Government authorization (ap-
proval reference number PI-010-2012). For NTHi infection,
bacteria were recovered with 1 ml PBS from a chocolate-agar
plate grown for 16 h, to obtain a suspension of ,56109 c.f.u./ml.
Before infection, mice were anesthetized by intraperitoneal
inoculation of a mixture of ketamine-xylazine (3:1). Each mouse
received 20 ml of inoculum (,108 c.f.u.) intranasally. Groups of 5
mice were euthanized and necropsied at selected intervals. Lungs
were aseptically removed, individually weighed in sterile bags
(Stomacher80, Seward Medical), homogenized, and serially ten-
fold diluted in PBS. Each dilution was spread on sBHI-agar plates
to determine the number of viable bacteria (detection limit ,
10 c.f.u./lung). The individual number of c.f.u./lung was loga-
rithmically transformed for data normalization. Statistical com-
parisons of mean log10 c.f.u./lung were performed by a one-way
ANOVA followed by the Fisher’s Protected Least Significant
Differences (PLSD) tests using the Stat View Graphics 5.0 for
Windows (SAS Institute Inc) statistical package. A p,0.05 value
was considered statistically significant.
Sequencing, Assembly and Comparison of three Clonal
Isolates’ Genomes
Genomic DNA samples were extracted from the three isolates
from patient 1, NTHi1a, 1b, 1c, and a derivative of the completely
sequenced isolate 86-028NP, RR3131 [32,33] using standard
methods [23]. Samples were converted to sequencing libraries
using the Nextera-XT kit (Illumina) and included in a multiplexed
Illumina HiSeq RapidRun, collecting 26101 nucleotide paired-
end reads. Raw data was then converted to FastQ format using
bcl2fastq-v1.8.4 (Illumina). Genome assemblies were performed
with a 5-step pipeline: (i) Nextera adaptor sequences were trimmed
from reads using Trimmomatic-v0.30 [34]; (ii) overlapping paired-
end reads were joined using COPE-v1.1.2 [35]; (iii) error
correction was performed using ALLPATHS-LG stand-alone
ErrorCorrectReads.pl utility [36]; (iv) optimal kmer size was
estimated using kmergenie-v1.5658 [37]; and (v) finally, de novo
assembly was performed using Ray-v2.2.0 [38]. Assembly quality
was assessed using whole-genome alignment with Mauve-v2.4 [39]
of the contigs generated from the RR3131 strain to the 86-028NP
complete genome sequence from NCBI (GenBank accession
NC_007146.2). Synteny was evaluated iteratively applying the
Mauve ‘‘Move Contigs’’ utility with 86-028NP as the reference
sequence. Finally, contigs were annotated using the automated
web service RAST [40], and the resulting GFF3 output was parsed
to generate a BED file of protein coding sequences. Sequence data
for strains NTHi1a, 1b and 1c were deposited to the NCBI under
project accession number PRJNA240637.
To identify variants between the three isolates, the original
paired-end reads of each sample were realigned to each set of
contigs using the mem algorithm in bwa-v0.7.5a-r405 [41], and
samtools/bcftools were used to identify single-nucleotide variants
and small indels distinguishing the three strains [42]. Variant calls
in VCF format were then filtered to exclude those positions with
‘‘heterozygous’’ or ambiguous base calls in any of the three strains,
as these likely represent systematic sequencing artifacts. The
remaining variants were then intersected against the BED
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annotation using the intersect utility in bedtools-v2.16.2 [43]
to obtain a list of variants within coding sequences. The
bedtools utility getFasta was used to extract the relevant
ORFs, and the R package seqinr [44] was used to perform
translations of variant coding sequences. Web-based BLASTP
of the set of protein sequences containing nonsynonymous
differences was used to manually curate the RAST annotations
and facilitate literature searches for previous experimental work in
H. influenzae.
Results
NTHi Isolates Collected from Adult Patients with
Obstructive Lung Disease
NTHi isolates used in this study were recovered from sputum
samples from 18 episodes of acute exacerbations in 6 adult patients
with chronic lung diseases (4 COPD, 1 bronchiectasis, 1 cystic
fibrosis and bronchiectasis). Patients were attended at Hospital
Universitario Bellvitge, Spain, when they had symptoms suggest-
ing an exacerbation. Table 1 summarizes clinical and demo-
graphic characteristics of these patients, antibiotic resistance
patterns, pulse field gel electrophoresis (PFGE) profiles, and
genetic features of NTHi isolates.
NTHi isolates were typed by PFGE and divided in two groups
(Table 1): (i) persistent isolates had identical PFGE profile to those
isolated from previous sputa in the same patient. Patients 1, 2 and
3 belonged to this category, and rendered three series of clonal
isolates that we considered as persistent. (ii) Newly acquired
isolates showed a PFGE profile different than those isolated from
previous sputa in the same patient. Patients 4, 5 and 6 belonged to
this category, and isolates recovered from these patients were
considered as newly acquired. The series recovered from patient 3
contained one newly acquired (NTHi3a) and two persistent
isolates (NTHi3b and 3c).
Antibiotic susceptibility of the 18 NTHi isolates is shown in
Table 2. All isolates were susceptible to amoxicillin/clavulanic
acid, cefuroxime, ceftriaxone, cefotaxime, imipenen, meropenem,
tetracycline, chloramphenicol, trimethoprim/ sulfamethoxazole,
azithromycin, ciprofloxacin, levofloxacin and rifampicin. Con-
versely, three isolates were resistant to ampicillin due to b-
lactamase production, and five isolates presented intermediate
resistance without b-lactamase production. All but six isolates were
resistant to trimethoprim/ sulfamethoxazole. Finally, persistent
isolates were identical in terms of antibiotic susceptibility, within
each patient.
Lipooligosaccharide Gene Distribution and Phase
Variation on NTHi Isolates Collected from Adult Patients
with Obstructive Lung Disease
Lipooligosaccharide (LOS) is a heterogeneous surface structure
on NTHi, partly due to a strain variable distribution of the genes
encoding the enzymes required for its biosynthesis, being some of
them phase variable [45]. We used PCR and DNA sequencing to
evaluate all isolates for the presence of genes encoding enzymes
required for the biosynthesis of LOS. Five of these genes were
present in all strains: lgtF (glycosyltransferase responsible for
adding glucose as the first sugar to HepI in the LOS molecule),
lic2A (glycosyltransferase required to add a digalactose to the
LOS), lpsA (glycosyltransferase responsible for adding glucose or
galactose as the first sugar to HepIII in the LOS molecule), lic3A
and lic3B (sialyltransferases). The presence of lic2B and lic2C was
variable (Table 1). Given that lic2B and lic2C encode two
glycosyltransferases involved in sugar extension from HepII in
the LOS molecule, this extension is likely to be variable among
strains. PCho addition to the LOS molecule requires the lic1ABCD
operon [20], present in all strains tested. The lic1A gene is
phase variable due to a variable number of tetranucleotide (59-
CAAT-39) repeats in its coding sequence. Gel electrophoresis
revealed lic1A size differences among isolates, correlating with lic1A
gene sequences containing between 6 and 41 59-CAAT-39
repeats (Table 1). The lic1A gene has been shown to present
3 potential translational initiation codons and 2 potential
initiation codon-containing frames [46]. Taking these
alternatives into consideration, the lic1A gene was likely to be
phase ON in most NTHi strains tested. Only strains with 17
repeats in the lic1A gene seemed to be phase OFF, independently
of the translational initiation codon and frame considered
(Table 1). Of note, when PCho decoration was monitored by
colony immunoblot, it was found to be present in all strains. NTHi
colonies were observed to exhibit variable reactivity with TEPC-
15, classified as high and low, as previously reported [20]. The
distribution of PCho-reactive colony types was variable among
strains (Table 3).
Infection of Airway Epithelial Cells by NTHi Isolates
Collected from Adult Obstructive Respiratory Patients
Bacterial pathogens gaining access to the lower airways of
patients are likely to infect airway epithelial cells, and epithelial
adhesion is in many cases an important stage of the infectious
process [47]. We observed that adhesion of persistent NTHi
strains recovered from patients 1 to 3 to A549 airway epithelial
cells was significantly lower than that shown by newly acquired
strains from patients 4 to 6 (Fig. 1A). hmw1A and hmw2A gene
expression has been shown to decrease for persistent NTHi over
time [9]. PCR evaluation showed that the hmw1A gene is absent in
NTHi strains recovered from patients 1 and 2, limiting its
potential implication in the observed phenotype.
P5 has been shown to be a bacterial ligand for the
carcinoembrionic antigen molecule-1 CEACAM1 receptor [48].
PCR amplification showed that the ompP5 gene was size invariable
among the isolates tested for epithelial adhesion. Sequence
variability of the ompP5 gene has been previously reported [17].
For this reason, we sequenced each predicted OmpP5 extracel-
lular loop (a prediction based on a PRED-TMBB b-barrel) on the
NTHi isolates under study. The ompP5 sequence was heteroge-
neous among strains; however, clonal isolates showed identical
sequence in loops 1 to 5 (Table S1 in File S1). A comparable motif
distribution for loop 1, encompassing GINNNGAIK/Q (red) or
GLRALARE (blue) sequence, has been reported previously [49].
Loop sequences highlighted in grey were found in our previous
study [17].
NTHi infection triggers the secretion of pro-inflammatory
cytokines by epithelial cells [50]. A549 cell infection by strains
NTHi1a, 5a and 5b promoted the secretion of IL-8 levels
significantly higher than the basal level registered for non-infected
cells, both at 6 and 20 h post-infection (Fig. 1B). Most other strains
promoted the secretion of slight but not significant IL-8 levels;
NTHi6a did not stimulate IL-8 secretion above the level seen in
non-infected cells.
Collectively, these results showed that persistent NTHi isolates
have low rates of adhesion to cultured epithelial cells, compared to
the newly acquired strains tested. This observation was not
associated with the variable sequence of the ompP5 gene. In
general, these isolates induced relatively low levels of epithelial IL-
8 secretion.
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Self-aggregation and Biofilm Formation by Persistent
NTHi Isolates
NTHi self-aggregates, which may promote microcolony forma-
tion on host cell surfaces [51]. We asked whether self-aggregation
differs between the NTHi isolates under study, by using tube-
settling assays and monitoring the optical density of bacterial
suspensions over time with a non-aggregating E. coli strain C600 as
control. Strains recovered from the same patient self-aggregated at
the same rate. The series isolated from patient 3 did not self-
aggregate (p,0.0001 from 1 h to the end of the assay). The series
isolated from patient 1 self-aggregated significantly slower than
that recovered from patient 2 at early time points (p,0.0001 at
1 h; p,0.001 at 1.5 h). NTHi6a presented OD600nm values higher
than those obtained for strains from patients 1 and 2 (p,0.0001 at
1 and 1.5 h), and lower than isolates from patient 3 (p,0.0001, all
time points tested) (Fig. 2, Table S2 in File S1). We have previously
reported that bacteria lacking PCho self-aggregate slightly faster
[31]. All strains tested displayed PCho, excluding its association
with the observed phenotypes.
We also asked whether the available persistent isolates could
form biofilms. We tested the formation of biofilm communities
under continuous-flow culture conditions in microfermenters by
measuring the turbidity of bacterial suspensions detached from
removable glass slides. No biofilm could be visualised among
isolates from patients 1, 2 and 3 (Table 4). NTHi5a, 5b and 6a
were tested as a sample of newly acquired strains, and formed
biofilms. NTHi biofilm growth has also been related to PCho [31].
Given that all strains tested for biofilm growth displayed PCho, we
excluded an association between PCho and the observed
phenotypes. In sum, we observed that, under the conditions
tested, persistent NTHi isolates recovered from patients 1 to 3 do
not develop biofilm communities.
Persistent NTHi Isolates Display Increasing Resistance to
Antimicrobial Peptides
Antimicrobial peptides (AMPs) are positively charged innate
immunity soluble peptides whose action is initiated through
electrostatic interaction with the bacterial surface, the anionic lipid
A moiety of the lipopolysaccharide (LPS) in Gram-negative
bacteria [52–55]. Polymyxins are pentacationic amphipathic
lipopeptide antibiotics active against Gram-negative bacteria
and, similar to AMPs, they interact with the anionic LPS
[56,57]. We examined the susceptibility of the three series of
clonal NTHi isolates to AMP mediated killing by incubating them
for 60 min with a range of concentrations of polymyxin B (PxB).
Resistance to killing varied modestly, but the later persistent
isolates were consistently more resistant than the corresponding
original isolates (Table 5). This observation became clearer when
strains were incubated with PxB for 30 min (Table 6). Likewise, we
found increasing resistance to the natural AMP human b-defensin-
1 (hBD-1) among isolates with the same PFGE profile (Table 6). In
sum, a progressive increasing resistance to PxB and hBD-1 could
be observed on the series of persistent NTHi isolates under study.
Increasing Resistance to AMPs is not Related to Changes
in LOS Decoration with PCho or Lipid A Acylation
NTHi resistance to AMPs has been related to LOS decoration
with PCho [31,58]. All strains tested for AMPs susceptibility
displayed PCho, excluding its involvement in the observed
increasing resistance. Lipid A acylation has also been linked to
NTHi resistance to AMPs [59]. We characterized the lipid A
moieties of strains NTHi1a to 1c, 2a, 2b, 3a to 3c, and 5a by
MALDI-TOF mass spectrometry. Spectra were similar for the
isolates tested (Figure S1A in File S1). Previous studies determined
that the lipid A disaccharide backbone of NTHi is composed of
Table 3. PCho expression by NTHi isolates.
Patient Isolate aHigh reactivity (% of colonies) Low reactivity (% of colonies)
1 NTHi1a 71.1 28.9
NTHi1b 51.2 48.8
NTHi1c 77.5 22.5
2 NTHi2a 32.2 67.8
NTHi2b 5.9 94.1
3 NTHi3a 93.8 6.2
NTHi3b 0 100
NTHi3c 13.8 86.2
4 NTHi4a 100 0
NTHi4b 10.8 89.2
NTHi4c 7.3 92.7
NTHi4d 47.8 52.2
5 NTHi5a 100 0
NTHi5b 96.5 3.5
NTHi5c 94.3 5.7
NTHi5d 3.8 96.2
6 NTHi6a 95.2 4.8
NTHi6b 7.2 92.8
aPCho expression was detected by colony immunoblot with the anti-PCho monoclonal antibody TEPC-15. Strains were classified by colony reactivity with the TEPC-15
antibody as previously described [20]. The intensity of TEPC-15 signal rendered by each colony was determined as high or low. Percentages were calculated by
assessing colony reactivity for at least 300 colonies per strain, in at least two independent experiments.
doi:10.1371/journal.pone.0097020.t003
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two 2-amino-2-deoxyglucose residues (GlcNI and GlcNII) linked
by a b-(1–6) glycosidic linkage and phosphorylated at positions 1
and 49. The C2/C29 and C3/C39 positions are substituted by
amide-linked and ester-linked 14:0(3-OH), respectively. Fatty acid
chains on C39 and C29 are further esterified by 14:0 [60]. The
isolates analyzed in this work showed a major lipid A species
corresponding to the same hexa-acylated form (m/z 1,824)
described by Mikhail and co-workers. Other ion peaks detected
(m/z 1,744, and m/z 1,388) had also been previously found [60].
These peaks may represent the monophosphorylated hexa-
acylated lipid A, and a tetra-acyl lipid A containing two 2-
amino-2-deoxyglucose residues, two phosphates, three 14:0(3-
OH), and one 14:0(3-OH), respectively (Figure S1A and Table S3
in File S1).
Together, the increasing resistance to PxB and to hBD-1
observed on the three series of persistent isolates could not be
associated with variations in PCho decoration or in the lipid A
acylation profile of the LOS molecule.
Persistent Isolates from Patient 1 Display Similar Growth,
Competence and Murine Pulmonary Infection Capacity
We further characterized one series of isolates identical by
PFGE but distinct in terms of resistance to AMPs. We selected the
three isolates recovered from patient 1, NTHi1a, 1b and 1c. We
first characterized the lipid A moieties when bacteria were grown
in the presence of sub-lethal concentrations of PxB. Results were
identical to those obtained when bacteria were grown without PxB
(Figure S1A in File S1). Next, we compared the growths of the
three isolates in rich broth (sBHI medium) by using a BioScreen
incubator. The three isolates had growth curves indistinguishable
from each other (Figure S1B in File S1). Growth was compared
with that of the reference strain H. influenzae RdKW20. The four
strains tested rendered identical slopes. H. influenzae is naturally
competent. If sequence homology permits, incoming DNA can
recombine with the chromosome. When this recombination
changes the genotype, the cell is said to be transformed. Evidence
indicates that NTHi strains can differ considerably in the amount
of DNA they take up and recombine [61]. Given that natural
transformation is a major mechanism of genetic exchange that
Figure 1. Infection of epithelial cells by NTHi isolates recovered from chronic respiratory patients. (A) NTHi adhesion to A549 epithelial
cells. NTHi cells were incubated with A549 cells for 30 min. Bacterial adhesion was quantified by lysis, serial dilution and viable counting on sBHI-agar
plates. Mean numbers for newly acquired strains (grey bar) were significantly higher (p,0.0001) than those obtained for strains recovered from
patients 1, 2 and 3 (white bar). (B) Stimulation of IL-8 secretion by infection for NTHi clinical isolates. Quantification by ELISA of IL-8 secreted to the
supernatant by A549 cells upon infection with NTHi1a, 1b, 1c, 2a, 2b, 3a, 3b, 3c, 5a, 5b, 5c 5d and 6a. [IL-8] was quantified at 6 (white bar) and 20 (grey
bar) h post-infection.
doi:10.1371/journal.pone.0097020.g001
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shapes bacterial genomes and allows pathogens to evade the host
immune response, we asked if NTHi1a, 1b, 1c are competent and,
if so, if their competence phenotypes differ. Competence was
assessed by transformation assays. The three strains developed
competence under the conditions tested, and displayed compara-
ble transformation phenotypes (Figure S1C in File S1). Finally,
pulmonary infection by NTHi1a, 1b and 1c was assessed by
intranasal inoculation of CD1 mice, and quantification of bacterial
loads from lung homogenates of infected mice was performed at
24 and 48 h post-infection (PI). At 24 h PI, the three strains
delivered counts indistinguishable from each other. At 48 h PI,
infections were almost cleared in the three groups of animals
(Figure S1D in File S1).
In sum, the series of clonal isolates recovered from patient 1
showed comparable growth, transformation frequency and murine
pulmonary infection rate. Together, these clonal isolates presented
similar phenotypic traits, except for their resistance to AMPs.
Genome Sequence Comparison of Serial Isolates NTHi1a,
1b, 1c Reveals Amino Acid Differences in the Permease
SapC, four Heme uptake Systems, the Kdo Kinase KdkA,
the Long-chain Fatty Acid Transporter OmpP1, and in the
Phosphoribosylamine Glycine Ligase PurD
Given that the three isolates from patient 1 had the same PFGE
profile and were phenotypically indistinguishable, except for their
resistance to AMPs, increasing between NTHi1a and isolates
NTHi1b and 1c, we hypothesized that the three isolates were likely
drawn from the same population of H. influenzae, and that host
selection pressures may have caused the change in AMP
resistance. To confirm that the isolates were closely related, and
to identify candidate genetic variants responsible for the pheno-
typic change, we performed whole genome sequencing on all
three. As a control to evaluate the accuracy and completeness of
our genome assembly pipeline, we included a derivative of the
completely sequenced H. influenzae isolate 86-028NP (RR3131)
[32,33]. Comparison of the contigs generated for this control
strain to the complete sequence of 86-028NP using the Mauve
aligner [39] demonstrated that the sequencing and assembly was
not only nearly complete (99% of the genome was covered, with
most of the missing 20,000 bp accounted for by the unassembled
rDNA repeats (Figure S2 in File S1), but also highly accurate (all
76 of the single-nucleotide variants detected between the contigs
and the complete sequence were previously identified and no other
variants were detected). The high quality of the RR3131 assembly
gave us high confidence in the three bronchiectasis isolate draft
assemblies. Summary statistics for the sequencing and assembly of
all four sequenced isolates are provided in Table S4 in File S1.
Isolates NTHi1a, 1b and 1c were extremely closely related.
Synteny was evaluated by iteratively reordering the contigs against
the 86-028NP reference using Mauve; this found that gene order
between the three isolates was highly conserved, corroborating the
PFGE fingerprints but at higher resolution (Figure S3 in File S1).
Single-nucleotide variants (SNVs) were identified that distin-
guished the three isolates using stringent criteria (see Methods
section). This found a total of 54 SNVs, clearly demonstrating the
very close relationship between the strains (the average pair of H.
influenzae isolates differ by ,40,000 SNVs). 45 of the variants were
in coding sequences, and 39 of these caused nonsynonymous
changes in 19 different genes (Table 7). This high proportion of
nonsynonymous changes strongly suggests that these changes are
selectively beneficial. These genes encode proteins belonging to
the following functional categories: permease involved in resis-
tance to AMPs and in heme uptake (1), heme/haemoglobin/
haptoglobin acquisition (5), LOS biosynthesis (1), outer membrane
(1), metabolism (7), transporters (4) (Table 7). Except for three
SNVs in a single gene, every SNV was either present in both later
isolates or only in isolate NTHi 1c, supporting the hypothesis that
Figure 2. H. influenzae clinical isolates self-aggregation. Tube-
settling experiment of stationary phase cultures of isolates NTHi1a
(open circles), NTHi1b (open squares), NTHi1c (open triangles), NTHi2a
(black inverted triangle), NTHi2b (black diamond), NTHi3a (grey circle),
NTHi3b (grey square), NTHi3c (grey triangle), NTHi5b (open inverted
triangle) and NTHi6a (open diamond), after incubation at room
temperature for 7 h. E. coli C600 (asterisk) was used as a negative
control. Bacterial aggregation was quantified by measuring the
decrease of absorbance at OD600nm. NTHi1a-1c self-aggregated
significantly slower than NTHi2a-2b (p,0.0001 at 1 h; p,0.001 at
1.5 h). NTHi6a aggregated slower than strains from patients 1 and 2
(p,0.0001 at 1 and 1.5 h), and faster than isolates from patient 3 (p,
0.0001, all time points tested).
doi:10.1371/journal.pone.0097020.g002
Table 4. Biofilm formation under continuous-flow conditions,
in microfermenters containing glass slides where bacteria
formed the biofilm.
Patient Isolate
OD600nm of bacterial suspension
detached from glass slide
1 NTHi1a 0.001
NTHi1b 0.00160.001
NTHi1c 0.00460.001
2 NTHi2a 0.000560.0007
NTHi2b 0.001560.002
3 NTHi3a 0.003560.001
NTHi3b 0.01260.016
NTHi3c 0.15460.21
5 NTHi5a 1.3160.28a
NTHi5b 1.6560.28b
6 NTHi6a 1.5760.35a
Data shown are means and SD of absorbance values, compared by a two tail t
test. NTHi5a and NTHi6a formed a biofilm significantly higher than the non-
existing ones obtained for isolates from patients 1, 2 and 3, ap,0.005. NTHi5b
formed a biofilm significantly higher than the non-existing ones obtained for
isolates from patients 1, 2 and 3, bp,0.0005.
doi:10.1371/journal.pone.0097020.t004
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NTHi1a is an ancestor of NTHi1b, and NTHi1b is an ancestor of
NTHi1c. At ompP2 (ORF1641), 3 of the 13 SNVs were
inconsistent with stepwise mutation accumulation. The most likely
explanation is that one of the ompP2 alleles in NTHi1b and
NTHi1c was independently derived by recombination with
another H. influenzae strain in the patient’s overall population, as
was previously reported for NTHi ompP2 alleles in a COPD
patient [8].
To identify candidate variants responsible for AMP resistance,
we focused on the nine loci containing coding SNVs present in
both NTHi1b and NTHi1c, since these strains have similar AMP
resistance (Table 7). A good candidate for the increase in AMP
resistance is the T79A change in SapC, a permease translocator of
the SapABCDZ system involved in NTHi resistance to AMPs and
in heme utilization [62]. Four other genes in this set of nine were
iron transporters: hgpC, hup, hgpB, and hxuC. We found three amino
acid changes in HgpC: D398G, E433K and T895I; three changes
in Hup: P280T, D291Y and T555A; and three changes in HgpB:
S40L, Y116H and D320N. The change in HxuC is most likely a
null mutation due to the early stop codon W133*. Although the
consequences of variation in these iron transporters are not
known, the multiple changes strongly suggest the action of natural
selection. We also found the amino acid change Q226H in the
sequence of KdkA, a kinase encharged of 3-deoxy-D-manno-
octulosonic acid (Kdo) phosphorylation; the amino acid change
G96V in the long-chain fatty acid transporter OmpP1; and the
amino acid change P278T in the phosphoribosylamine-glycine
ligase PurD.
We pursued the variation observed in the sapC and kdkA genes,
by sequencing these two genes in the isolates recovered from
patient 2 and 3. We observed sequence variation among patients
(amino acids shown in bold, Figure S4 and Figure S5 in File S1).
Clonal isolates within each patient had identical sapC and kdkA
sequences, excluding a possible involvement of SNVs in these two
genes in the increasing resistance to AMPs observed for isolates
recovered from patients 2 and 3.
In sum, whole genome sequence of the three clonal isolates from
patient 1 revealed amino acid changes that could account for the
observed increasing resistance to AMPs in isolates NTHi1b and
1c, compared to NTHi1a.
Discussion
Understanding chronic infection by NTHi associated with
obstructive lung disease in adults is relevant due to its implications
for the progression of the disease. In this work, we examined a
range of phenotypic traits associated with pathogenesis in three
series of NTHi clonal isolates recovered from three obstructive
lung disease patients. Each series contained two or three isolates
with identical PFGE profile, recovered from sputum samples from
patients in acute condition during different medical visits. This is,
to our knowledge, the first phenotypic study on series of clonal
NTHi isolates recovered from adult respiratory patients which is
not restricted to COPD. Phenotypes were compared to those
shown by a number of newly acquired strains.
Persistent isolates were distinguished by epithelial infection and
biofilm growth: they adhered poorly to epithelial cells and did not
form biofilms. Adhesion data agree with the observation that H.
influenzae isolates recovered from COPD exacerbation adhere to
airway epithelial cells more strongly than colonisers [12]. P.
aeruginosa isolates obtained from chronically infected patients also
showed a reduced ability to associate with A549 cells [63]. Low
adhesion may dampen pathogen-induced inflammatory responses
of respiratory epithelial cells, favouring host immunity evasion.
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This observation may be relevant, given that host inflammation is
crucial for the effective clearance of infections. Our data show a
limited stimulation of IL-8 secretion by epithelial cells upon
infection with NTHi strains. These results agree with a previous
report showing that newly acquired NTHi strains infecting the
airway during COPD exacerbation induce more IL-8 secretion by
epithelial cells than colonizers [12]. NTHi biofilm has also been
shown to be a variable feature [64], associated with pediatric
nasopharyngeal carriage [65] and CF persistence [66], but not
with COPD colonization [12]. Here, we observed that the three
series of persistent isolates did not form a detectable biofilm on
microfermenters glass slides, unlike the newly acquired isolates. Of
note, P. aeruginosa biofilm formation by non-mucoid CF isolates
follows a trend of decreased adherence with progression of the
chronic lung infection [67], and non-attached aggregates have
been related to P. aeruginosa ability to cause chronic infection [68].
Like epithelial adhesion, biofilm growth is considered to be an
important event in early stages of NTHi infection. The relation-
ship between the phenotypic trends observed and persistent
infection by NTHi is currently unknown. Self-aggregation
clustered isolates by patient. Given that NTHi is well adapted to
its human host, self-aggregation could be a host-dependent
adaptive phenotype, with unknown implications in pathogenesis.
We observed an increasing resistance to AMPs in the three
series of persistent isolates tested. LOS decoration with PCho and
lipid A acylation did not account for this observation. All strains
rendered a PCho signal, despite the fact that some of them
contained a phase OFF lic1A gene, according to the number of
repeats. Evidence points out that PCho expression may also be
influenced by a second lic1 locus that allows for dual PCho
substitutions in the same strain [69], which could also contribute to
explain the observations shown in this study. LOS decoration with
PCho and lipid A acylation prompted us to further analyse the
series of three strains recovered from patient 1. Genome sequence
revealed that these three isolates are not identical, despite
displaying the same PFGE profile. Given that increasing resistance
to AMPs was observed for NTHi1b and 1c, compared to NTHi1a,
we considered NTHi1a as a reference and looked for SNVs
present in both NTHi1b and 1c. We found one SNV in the sapC
gene, which belongs to the sapABCDZ operon, encoding a system
involved in NTHi resistance to AMPs. SapA, located at the
periplasm, binds AMP molecules that are translocated to the
bacterial cytoplasm through the SapBC translocon. Once in the
cytosol, AMP molecules are degraded. Whether the replacement
SapCT79A accounts for the observed increasing resistance to
AMPs in this series of isolates is currently unknown. SapABCDZ is
also involved in heme uptake [62]. H. influenzae does not synthesise
heme. To overcome this disability, it is endowed with several heme
uptake systems [70]. Together with sapC, we found polymorphisms
in the heme acquisition systems hgpB, hgpC, hup and hxuC. Given
that SapABCDZ conjugates AMPs resistance and heme uptake,
and based on the sequence data presented here, we speculate
about a potential crosstalk between bacterial systems responsible
for AMPs resistance and for heme acquisition. Although formally
different, Staphylococcus aureus small colony variants (SCVs), which
are impaired in heme biosynthesis, show reduced susceptibility to
the AMP lactoferricin B [71]. We should also consider the
observed SNVs in genes encoding heme uptake systems as possible
adaptations to overcome host nutritional immunity. In fact,
restriction of heme-iron in the host may foster long-term
phenotypic changes that better equip NTHi for survival at
infection sites [72]. Whether there is a relationship between
phenotypic changes linked to nutritional immunity and genome
changes is unknown. Clonal adaptation to iron limitation has been
reported for Burkholderia cenocepacia [73], which, in that case, may
be related to up-regulation of genes involved in iron uptake [74].
We also found a SNV in the Kdo kinase gene kdkA. The amino
acid sequence motif of the active site of KdkA has been elucidated
Table 6. NTHi strains resistance to Polymyxin B and to human b-defensin 1 mediated killing after a 30 min bacterial incubation
with the AMP.
AMP Patient Isolate [AMP] (mg/ml)
1 0.75 0.5 0
PxB 1 NTHi1a 11.860.9 30.961.7 96612.7 100
NTHi1b 35.569.6a 69.369.4a 100 100
NTHi1c 36.768a 78.169.2a 100 100
2 NTHi2a 12.961.5 54.6611.1 96.765.1 100
NTHi2b 37.266.3a 74.362a 99.869.9 100
3 NTHi3a 26.567.3 4962.2 98.867.4 100
NTHi3b 34.463.4 55.4611.5 100 100
NTHi3c 51.766.1a 75.164a 100 100
hBD-1 1 NTHi1a 57.363.8 88.867.7 ND* 100
NTHi1b 84.563.7a 10065 ND 100
NTHi1c 91.264a 100 ND 100
2 NTHi2a 60.767.5 91.763.7 ND 100
NTHi2b 87.563.5a 100 ND 100
3 NTHi3a 68.369.6 90.663.7 ND 100
NTHi3b 87.160.6 100 ND 100
NTHi3c 94.862.8a 100 ND 100
*ND=not determined.
ap,0.05 vs. first strain with identical PFGE profile isolated from each patient.
doi:10.1371/journal.pone.0097020.t006
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previously [75], and does not include the amino acid position 226.
We lack evidence for KdkA involvement in NTHi resistance to
AMPs. However, disruption of kdkA in Pasteurella multocida increases
bacterial sensitivity to the bactericidal peptide fowlicidin [76]. In
addition, we found a SNV in the long chain fatty acid transporter
encoding ompP1/fadL gene. Interestingly, premature termination
of H. influenzae fadL has been previously found to confer resistance
to the antibacterial compound A-344583 [77]. Finally, we found a
SNV in the phosphoribosylamine glycine ligase encoding gene
purD. We lack evidence for NTHi purine biosynthesis relationship
with AMP resistance. However, S. aureus strains resistant to
vancomycin revealed increased transcription of up to 15 genes
involved in purine biosynthesis or transport [78].
Several reports have linked variation in phase variable genes to
NTHi adaptation or persistence: increasing number of single
sequence repeats in hmw1A and hmw2A promoter regions linked to
diminishing expression of HMW1A and HMW2A [9]; lic2A, lgtC
and lex2A switch from phase-off to phase-on following serial
passage in human serum, reducing binding of bactericidal
antibody to LOS [79]; licA and igaB switch from phase-off to
phase-on during experimental human nasopharynx colonization
by NTHi [80]. Differently, this is, to our knowledge, the first study
on clonal NTHi isolates where diversity has been assessed at the
genomic level, revealing a repertoire of newly found SNVs that
could be relevant for NTHi infection and persistence.
This investigation was performed on stored material, using only
a single colony from each original growth culture, so we cannot
exclude the presence of multiple H. influenzae strains in these
cultures. In COPD, both simultaneous presence of multiple H.
influenzae and the presence of one strain of H. influenzae in sputum
samples have been reported [7,81]. We acknowledge this
limitation in the present study.
In summary, we provide clues to nontypable H. influenzae
adaptation during infection. Due to its clinical relevance, a
comprehensive understanding of microbial traits associated with
NTHi persistence may help to establish guidelines applicable in
the prevention or treatment of chronic lung disease exacerbations.
Also, we found changes at the genome level that could account for
NTHi adaptation. Genome sequencing of sets of isolates
sequentially cultured from chronically infected patients has
revealed genome evolution and genetic adaptation for several
bacterial pathogens, including P. aeruginosa, Burkholderia dolosa or
Helicobacter pylori [82–85]. Further application of genome sequence-
based systematic approaches to long series of clonal variants will
deliver valuable information on NTHi adaptive strategies that may
offer new opportunities for treatment of NTHi infection in chronic
respiratory patients.
Supporting Information
File S1 This file contains Figures S1 to S5. Figure S1.
Characterization of serial clonal isolates recovered from patient 1,
NTHi1a, 1b and 1c. (A) Analysis of Haemophilus influenzae lipid A.
Representative negative ion MALDI-TOF lipid A mass spectra of
the different samples analyzed. Right panel: proposed structures of
the main molecular species present obtained. All strains tested,
both in the absence or in the presence of sub-lethal [PxB],
displayed identical lipid A structure. (B) Growth of NTHi1a, 1b,
1c and Rd KW20 in rich medium. Cells were grown in sBHI
broth in a BioScreen incubator with the OD600 nm recorded every
10 min. Each line shows the mean of 8 to 12 replicates for one
strain. Optical densities lower than 0.01 are not shown. To
account for differences in inoculum sizes, the lines have been
shifted along the x axis to superimpose the growth curves of all
strains. Color code: NTHi1a, red; 1b, yellow; 1c, green; Rd
KW20, blue. (C) Transformation frequencies of H. influenzae
strains NTHi1a, 1b and 1c. Vertical bars represent the means of at
least three biological replicates 6 standard deviations. We did not
observe significant differences. (D) Bacterial loads in the lungs of
CD1 mice infected by NTHi1a, 1b and 1c. Mice were infected
intranasally with 108 bacteria. Bacterial counts in lungs at 24 or
48 h PI were determined. Results are reported as log10 CFU/lung.
Lines inside boxes represent median values. Statistical differences
could not be observed among isolates NTHi1a, 1b and 1c. In the
three cases, bacterial recovery at 48 (white box) was significantly
lower than at 24 (grey box) h PI (p,0.0001). Figure S2. Control
assembly. Mauve alignment visualized after contig reordering
between the reference genome 86-028NP (top row) and the
RR3131 draft assembly (bottom row). The x-axis indicates
genome coordinate; the y-axis shows % nucleotide identity. The
vertical red lines indicate contig boundaries. Because the genomes
are circular, a single ‘‘inversion’’ is detected at the chromosome
‘‘ends’’ (green line). The six white gaps in the top row indicate the
six rDNA repeats in 86-028NP. Figure S3. Synteny between the
clinical isolates NTHi1a, 1b and 1c. Mauve alignment visualized
after iterative contig reordering between the three clinical isolates.
Rows from top to bottom are NTHi1a, NTHi1b, and NTHi1c.
The x-axis indicates genome coordinate; the y-axis indicates %
nucleotide identity. The vertical red lines indicate contig
boundaries. The white gap in NTHi1c represents 28 kb missing
from the assemblies of the others and likely indicates a novel phage
insertion. Figure S4. CLUSTAL 2.1 multiple sequence alignment
of SapC protein variants from patients 1, 2 and 3. Color code:
patient 1, red (T79A replacement in NTHi1b and 1c is highlighted
in turquoise); patient 2, blue; patient 3, black. SNV are indicated
in bold colored. Figure S5. CLUSTAL 2.1 multiple sequence
alignment of KdkA protein variants from patients 1, 2 and 3.
Color code: patient 1, red (Q226H replacement in NTHi1b and
1c is highlighted in turquoise); patient 2, blue; patient 3, black.
SNV are indicated in bold colored.
(PDF)
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